Octarine Bio ApS

CVR 39857316 · Private limited company (ApS) · Active · Low risk

Octarine Bio ApS is a Private limited company (ApS), founded on , based in København Ø. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.5% over the next 12 months, which is 0.4 times the average for Danish companies. 7 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 31.9m and a net result of DKK -11.5m. CEO: Nicholas Stuart William Milne.

Bankruptcy risk for Octarine Bio ApS

0.5%
probability of bankruptcy within 12 months
Low risk

0.4 × the average (1.41%) · higher risk than 59% of active Danish companies

Lowest riskHighest risk

Increases the risk

Return on assets< -20% · bankruptcy rate 16.7%1.9×
Going-concern uncertaintyYes · bankruptcy rate 16.3%1.9×
Website registeredYes · bankruptcy rate 12.0%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Annual reports filed late1 · bankruptcy rate 11.3%1.3×
Loss for the yearYes · bankruptcy rate 10.3%1.2×
Other companies at the same address20–100 · bankruptcy rate 10.2%1.2×

Reduces the risk

Current ratio500%+ · bankruptcy rate 1.5%0.17×
Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Time since new CEO5+ yrs · bankruptcy rate 3.8%0.43×
Share of late annual reports0.01%–25% · bankruptcy rate 4.5%0.51×
Number of auditors (historical)2 · bankruptcy rate 4.6%0.52×
Auditor registered in CVRYes · bankruptcy rate 4.8%0.55×
Audit opted outNo · bankruptcy rate 4.8%0.55×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
39857316
Status
Active
Company type
Private limited company (ApS)
Founded
(8 years)
Address
Lersø Parkallé 42, 1.
2100 København Ø
Municipality
København
Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Share capital
DKK 110k
Auditor
Ri Statsautoriseret Revisionspartnerselskab
Audit opted out
No

Warning signs

Annual reports filed late1 of 7
Missing annual reportNo
Negative equityNo
Equity ratio87.0%
Current ratio768%
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address34
Going-concern uncertaintyYes

Financials and key figures

Financial year20252024
Gross profitDKK 1.7mDKK 388k
Net profitDKK -11.5mDKK -22.3m
EquityDKK 31.9mDKK -44.7m
Total assetsDKK 36.7mDKK 27.9m
CashDKK 16.0m–
Short-term debtDKK 4.5m–
Avg. employees11–

Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Ri Statsautoriseret Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025175
1 Jan 2024 – 31 Dec 2024170
1 Jan 2023 – 31 Dec 2023169
1 Jan 2022 – 31 Dec 2022171
1 Jan 2021 – 31 Dec 2021172
1 Jan 2020 – 31 Dec 2020132
12 Sep 2018 – 31 Dec 2019234 Late

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEONicholas Stuart William MilneCurrent
BoardStephan ChristgauCurrent
BoardAlexandre Ouimet-StorrsCurrent
BoardAkshat KshetrapalCurrent
BoardNethaji Janeshawari GallageCurrent
BoardMarianne TochtermannCurrent
BoardAnna SøndergaardCurrent
BoardHelga Claudia Blomgren-Hansen
BoardChristian Brix Tillegreen
BoardLene Gerlach
BoardJonas Ahm-Lundgren
BoardAnna Sophie Zimmermann
Owner (10%)Nicholas Stuart William MilneCurrent
Owner (15%)Biosphere ApSCurrent
Owner (5%)UV Fund I K/SCurrent
Owner (5%)Danmarks Eksport- og InvesteringsfondCurrent
Owner (10%)The Footprint Fund I K/SCurrent
Owner (5%)Oskare Fund ICurrent
Owner (5%)DSM Venturing B.V.Current
Owner (5%)Ginkgo Bioworks, Inc.Current
Owner (33%)Nicholas Stuart William Milne
Owner (50%)Biosphere ApS
Owner (25%)Nicholas Stuart William Milne
Owner (20%)River Stone Biotech ApS
Owner (33%)Biosphere ApS
Owner (20%)Nicholas Stuart William Milne
Owner (10%)River Stone Biotech ApS
Owner (33%)Biosphere ApS
Owner (10%)Danmarks Eksport- og Investeringsfond
Owner (5%)The Footprint Fund I K/S
Owner (5%)Oskare Fund I
Owner (10%)Ginkgo Bioworks, Inc.
AuditorRi Statsautoriseret RevisionspartnerselskabCurrent
AuditorRi Magnoliavej 12 ApS
FounderNicholas Stuart William MilneCurrent
FounderBiosphere ApSCurrent

The CEOs' other companies

Nicholas Stuart William Milne – 1 other companies

Address history (2 moves)

Lersø Parkallé 42, 1., 2100 København Ø
Fruebjergvej 3, 2100 København Ø
c/o Nethaji Gallage, Howitzvej 20B, 2., 2000 Frederiksberg

Former names

Octarine Bio ApS – now
Octarine Bio IVS –

Other companies at the same address

Similar companies in København

Questions and answers about Octarine Bio ApS

Has Octarine Bio ApS gone bankrupt?

No, Octarine Bio ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Octarine Bio ApS?

Our model estimates a bankruptcy risk of 0.5% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.

Who is the CEO of Octarine Bio ApS?

Nicholas Stuart William Milne is the CEO of Octarine Bio ApS.

Who is the auditor of Octarine Bio ApS?

Octarine Bio ApS most recently used Ri Statsautoriseret Revisionspartnerselskab.

When was Octarine Bio ApS founded?

Octarine Bio ApS was founded on 12 September 2018.

What is the equity of Octarine Bio ApS?

Equity was DKK 31.9m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.